SCHEMBL12778366

SCHEMBL12778366

C/C(=N\OCc1ccc(C(F)(F)F)cc1)c1cc(Cl)ccc1NS(=O)(=O)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR9 P51686 2/20 0.42
S1PR1 P21453 1/20 0.41
PPARG P37231 3/20 0.40
PPARA Q07869 2/20 0.40
MRGPRX1 Q96LB2 1/20 0.37
HSPH1 Q92598 1/20 0.36
MAOB P27338 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
PPARD Q03181 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
DDR1 Q08345 1/20 0.35
LMNA P02545 1/20 0.35
MCL1 Q07820 1/20 0.35
P2RX1 P51575 1/20 0.35
P2RX4 Q99571 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12778373 0.94 MEN1 (0.40) PPARGPPARAMRGPRX1MAOBKMT2A
SCHEMBL12778427 0.92 P2RX1 (0.40) CCR9MRGPRX1KMT2AMEN1PTGS1
SCHEMBL12778385 0.90 L3MBTL1 (0.39) CCR9PPARGPPARAMRGPRX1KMT2A
SCHEMBL12778384 0.90 NPC1 (0.43) PPARGPPARAMRGPRX1L3MBTL1PTGS1
SCHEMBL12778369 0.89 LMNA (0.43) PPARGPPARAMRGPRX1HSPH1MAOB
SCHEMBL12778354 0.88 CCR9 (0.41) CCR9S1PR1PPARGPPARAMRGPRX1
SCHEMBL12778474 0.88 NPC1 (0.46) PPARAMRGPRX1KMT2AMEN1MAPT
SCHEMBL12778821 0.88 KDM1A (0.44) S1PR1PPARGPPARAMAOBKMT2A
SCHEMBL12778425 0.88 PTGS1 (0.37) S1PR1PPARGPPARAMRGPRX1KMT2A
SCHEMBL12778378 0.88 NPC1 (0.45) PPARGPPARAMRGPRX1MAOBPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7906538-B2 Parasiticides; nematocides; crop protection SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2011-03-15 US disclosed
US-20080262048-A1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2008-10-23 US disclosed
US-7312248-B2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2007-12-25 US disclosed
US-7312248-B2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2007-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262048-A1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF NOVEL TRIFLUOROMETHANESULFONANILIDE OXIME ETHER DERIVATIVES TRHDE, EPX, EPHX1 CCR9 1502/4885S1PR1 1229/4885PPARG 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.